drugset / Trial / NCT05341089
A Study of Two Different Formulations of LY3502970 in Healthy Participants
RandomizedCrossoverOpen-labelBasic science
Summary
The main purpose of this study is to conduct blood tests to measure how much LY3502970 is in the bloodstream when administered as two different formulations in healthy participants. The study will also evaluate the safety and tolerability of LY3502970. The study will last up to 13 weeks excluding the screening period.
Timeline
- Start
- 2022-05-17
- Primary completion
- 2022-09-01
- Completion
- 2022-09-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Orforglipron | Small molecule | 16 mg | Oral |
Indications
No indication recorded.